HomeMarketsU.S. EconomyModerna (MRNA): No Longer A One Hit Wonder?

Moderna (MRNA): No Longer A One Hit Wonder?

The Moderna (MRNA) stock price rose today after the flu vaccine showed promising results in a phase three trial. Is Moderna no longer a one hit wonder that was associated with Covid-19? The healthcare company expects to release 15 new products over the next 5 years. George Tsilis weighs in on possible upcoming booster shots.

Fast Market

13 Sep 2023

SHARE

ON AIR
6:00 pm
Next Gen Investing
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
ON AIR
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor